The US Food and Drug Administration has updated a template used to help developers provide the necessary data and information to the agency in support of a pre-emergency use authorization submission/EUA request for at-home molecular or antigen diagnostic COVID-19 tests.
The “Molecular and Antigen Home Use Test Template” now includes “updated recommendations and additional clarity for test developers,” the...